NIFEDIPINE vs NIRSEVIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NIFEDIPINE vs NIRSEVIMAB: Safety Overview
| Metric | NIFEDIPINE | NIRSEVIMAB |
|---|---|---|
| Total FAERS Reports | 8,266 | 247 |
| Deaths Reported | 1,081 | 5 |
| Death Rate | 13.1% | 2.0% |
| Hospitalizations | 2,637 | 149 |
| Average Patient Age | 54.2 yrs | 0.3 yrs |
| % Female Patients | 66.5% | 42.3% |
| FDA Approval Date | Approved Prior to Jan 1, 1982 | N/A |
| Manufacturer | Cardinal Health 107, LLC | Sanofi Pasteur Inc. |
| Route | ORAL | INTRAMUSCULAR |
| Marketing Status | Prescription | N/A |